M&A Deal Summary

Haemonetics Acquires Hemerus Medical

On May 1, 2013, Haemonetics acquired medical products company Hemerus Medical for 27M USD

Acquisition Highlights
  • This is Haemonetics’ 5th transaction in the Medical Products sector.
  • This is Haemonetics’ 6th largest (disclosed) transaction.
  • This is Haemonetics’ 10th transaction in the United States.
  • This is Haemonetics’ 1st transaction in Minnesota.

M&A Deal Summary
Date 2013-05-01
Target Hemerus Medical
Sector Medical Products
Buyer(s) Haemonetics
Deal Type Add-on Acquisition
Deal Value 27M USD

Target

Hemerus Medical

St. Paul, Minnesota, United States
website
Hemerus Medical LLC is a technologies for the collection of whole blood, and processing and storage of blood components. Hemerus has completed Phase 3 clinical trials and has submitted a New Drug Application to the FDA for its unique, patented SOLX® whole blood collection system.

Search 193,381 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Haemonetics

Boston, Massachusetts, United States

website

Category Company
Founded 1971
Sector Medical Products
Employees2,708
Revenue 993M USD (2022)
DESCRIPTION

Haemonetics is a healthcare company dedicated to providing innovative blood management solutions for our customers. Company devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Haemonetics was founded in 1971 and is based in Boston, Massachusetts.

DEAL STATS #
Overall 11 of 15
Sector (Medical Products) 5 of 8
Type (Add-on Acquisition) 10 of 14
State (Minnesota) 1 of 1
Country (United States) 10 of 12
Year (2013) 1 of 1
Size (of disclosed) 6 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-08-01 Pall - Transfusion Medicine Business

United States

Pall's Transfusion Medicine Business is a blood collection, filtration and processing product lines.

Buy $551M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-04-27 Haemonetics - SEBRA

Braintree, Massachusetts, United States

Haemonetics Corp. - SEBRA is a manufacturer of tube sealing equipment for blood and plasma centers worldwide. The SEBRA portfolio includes a suite of products used in blood collection and processing which can improve quality and regulatory compliance of blood products. Principal products include: Radio-Frequency (RF) Tube sealers that are used to seal and segment parts of the consumables used in blood collection, while maintaining a sterile environment for the collected blood. Sterility is critical in ensuring the highest quality blood component for transfusion. These benchtop and hand held sealers are used for blood collection and processing at blood banks, commercial plasma centers, stem cell processing facilities, and hospitals. SEBRA hand held sealers feature patented SMART™ circuitry that automatically adjusts for different sized tubing, and is certified for donor-connected use.

Sell -
Mergr

Product

Company

Legal